In 2023, the standardized mortality rate for bladder malignant neoplasms in the US was observed at 5.0 deaths per hundred thousand persons. The forecast from 2024 to 2028 indicates a gradual decline in mortality rates. Specifically, the rate decreases from 4.9 in 2024 to 4.7 in 2028, reflecting a steady downward trend in bladder cancer mortality.
- From 2024 to 2025, the year-on-year variation shows a decline of 2.0%.
- No change is noted between 2025 and 2026.
- Another 2.1% decrease is observed from 2026 to 2027.
- Stability is maintained between 2027 and 2028 with no variation.
The compound annual growth rate (CAGR) over these five years shows an average annual decrease of approximately 1.6% in mortality rate.
Future trends to watch for include advancements in early detection and treatment methods, which could further influence mortality rates. Additionally, shifts in healthcare policies and patient access to care may significantly impact these projections in the coming years.
